Whan In Pharm Co.,Ltd.
KRX:016580.KS
12540 (KRW) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 230,393.579 | 198,934.734 | 177,775.701 | 171,705.405 | 159,176.972 | 154,664.331 | 147,953.429 | 141,376.272 | 145,397.202 | 120,713.386 | 104,479.91 | 107,221.598 | 110,052.051 | 105,687.139 | 99,386.536 | 92,915.021 | 80,091.447 |
| Cost of Revenue
| 132,268.078 | 100,141.74 | 84,283.356 | 85,103.293 | 79,996.293 | 75,363.309 | 69,107.997 | 72,058.032 | 72,817.632 | 54,863.144 | 46,842.028 | 53,343.576 | 53,879.899 | 50,461.624 | 47,295.201 | 43,569.383 | 34,311.712 |
| Gross Profit
| 98,125.501 | 98,792.995 | 93,492.345 | 86,602.112 | 79,180.679 | 79,301.022 | 78,845.433 | 69,318.24 | 72,579.57 | 65,850.242 | 57,637.882 | 53,878.021 | 56,172.152 | 55,225.515 | 52,091.335 | 49,345.638 | 45,779.735 |
| Gross Profit Ratio
| 0.426 | 0.497 | 0.526 | 0.504 | 0.497 | 0.513 | 0.533 | 0.49 | 0.499 | 0.546 | 0.552 | 0.502 | 0.51 | 0.523 | 0.524 | 0.531 | 0.572 |
| Reseach & Development Expenses
| 1,072.478 | 3,330.765 | 2,659.158 | 3,312.379 | 993.271 | 647.767 | 1,167.063 | 827.775 | 619.794 | 0 | 0 | 0 | 0 | 0 | 94.891 | 1,807.445 | 3,695.555 |
| General & Administrative Expenses
| 18,729.287 | 17,590.687 | 15,938.218 | 14,923.211 | 16,003.933 | 12,261.672 | 11,007.153 | 12,618.209 | 10,803.032 | 10,033.585 | 9,125.925 | 8,493.36 | 8,011.647 | 9,176.242 | 9,334.971 | 8,499.514 | 6,263.597 |
| Selling & Marketing Expenses
| 17,688.884 | 17,700.621 | 13,140.732 | 10,649.384 | 7,561.822 | 12,103.99 | 13,424.452 | 10,777.822 | 8,750.626 | 6,593.608 | 6,477.268 | 4,954.774 | 6,016.047 | 6,448.206 | 8,347.155 | 8,298.313 | 6,358.699 |
| SG&A
| 65,571.728 | 35,291.308 | 29,078.95 | 25,572.595 | 23,565.755 | 24,365.662 | 24,431.605 | 23,396.031 | 19,553.658 | 16,627.193 | 15,603.193 | 13,448.134 | 14,027.694 | 15,624.448 | 17,682.126 | 16,797.827 | 12,622.296 |
| Other Expenses
| -1,311.007 | 30,360.502 | 30,478.442 | 29,298.827 | 28,456.979 | -238.812 | 5,969.206 | -156.87 | -167.448 | -1,341.026 | -532.569 | -681.132 | -507.763 | -701.101 | -873.845 | -1,358.456 | -757.021 |
| Operating Expenses
| 67,955.213 | 68,982.575 | 62,216.55 | 58,183.801 | 53,016.005 | 51,958.312 | 49,194.44 | 47,693.167 | 47,167.443 | 41,844.943 | 37,488.494 | 35,587.375 | 36,081.841 | 34,889.604 | 34,201.1 | 34,203.614 | 31,101.849 |
| Operating Income
| 30,170.288 | 29,810.42 | 31,275.795 | 28,418.312 | 26,164.674 | 27,342.71 | 29,650.993 | 21,625.073 | 25,412.128 | 24,005.299 | 20,149.388 | 18,290.647 | 20,090.311 | 20,335.911 | 17,890.235 | 15,142.027 | 14,677.884 |
| Operating Income Ratio
| 0.131 | 0.15 | 0.176 | 0.166 | 0.164 | 0.177 | 0.2 | 0.153 | 0.175 | 0.199 | 0.193 | 0.171 | 0.183 | 0.192 | 0.18 | 0.163 | 0.183 |
| Total Other Income Expenses Net
| 4,628.978 | -2.256 | 2,605.733 | 2,663.481 | 2,057.802 | 1,980.138 | 6,820.722 | 164.27 | 1,206.606 | 191.658 | 1,281.268 | 1,975.842 | -1,154.276 | 1,256.009 | 626.368 | 283.038 | 944.636 |
| Income Before Tax
| 34,799.266 | 29,808.164 | 33,881.528 | 31,081.793 | 28,222.476 | 29,322.848 | 36,471.715 | 21,789.343 | 26,618.733 | 24,196.957 | 21,430.656 | 20,266.488 | 18,936.035 | 21,591.92 | 18,516.603 | 15,425.062 | 15,622.522 |
| Income Before Tax Ratio
| 0.151 | 0.15 | 0.191 | 0.181 | 0.177 | 0.19 | 0.247 | 0.154 | 0.183 | 0.2 | 0.205 | 0.189 | 0.172 | 0.204 | 0.186 | 0.166 | 0.195 |
| Income Tax Expense
| 4,018.99 | 6,074.577 | 7,423.022 | 7,890.496 | 9,610.499 | 7,804.889 | 9,299.404 | 5,391.888 | 6,109.072 | 5,391.421 | 6,850.507 | 4,469.925 | 4,323.958 | 4,355.012 | 4,082.053 | 4,270.825 | 4,346.897 |
| Net Income
| 29,774.322 | 23,921.351 | 26,659.6 | 23,387.79 | 18,695.95 | 21,517.959 | 27,172.311 | 16,397.455 | 20,509.661 | 18,805.535 | 14,580.149 | 15,796.563 | 14,612.077 | 17,236.908 | 14,434.55 | 11,154.237 | 11,275.625 |
| Net Income Ratio
| 0.129 | 0.12 | 0.15 | 0.136 | 0.117 | 0.139 | 0.184 | 0.116 | 0.141 | 0.156 | 0.14 | 0.147 | 0.133 | 0.163 | 0.145 | 0.12 | 0.141 |
| EPS
| 1,950.23 | 1,566.86 | 1,746.22 | 1,531.91 | 1,224.59 | 1,409.44 | 1,780 | 1,074 | 1,343 | 1,232 | 955 | 1,035 | 968 | 1,183 | 954 | 735.5 | 728.5 |
| EPS Diluted
| 1,950.23 | 1,566.86 | 1,746.22 | 1,531.91 | 1,224.59 | 1,409 | 1,780 | 1,074 | 1,343 | 1,232 | 955 | 1,035 | 968 | 1,183 | 954 | 735.5 | 728.5 |
| EBITDA
| 36,810.764 | 37,724.098 | 37,987.238 | 34,214.069 | 32,366.49 | 30,144.492 | 33,265.041 | 25,240.276 | 27,990.394 | 26,834.451 | 22,252.306 | 19,366.538 | 23,989.567 | 22,333.239 | 20,125.551 | 17,019.178 | 17,449.667 |
| EBITDA Ratio
| 0.16 | 0.19 | 0.214 | 0.199 | 0.203 | 0.195 | 0.225 | 0.179 | 0.193 | 0.222 | 0.213 | 0.181 | 0.218 | 0.211 | 0.202 | 0.183 | 0.218 |